Loading
Life sciences · Journal article
Future Science Oa · September 10, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest solid malignancies despite advances in surgery, perioperative care, and systemic therapies. Pretherapeutic radiological sarcopenia has emerged as a clinically relevant body-composition phenotype associated with poor outcomes in oncology. This imaging-based concept differs from contemporary geriatric definitions of sarcopenia, which require impaired muscle strength and incorporate low muscle quantity and/or quality. This narrative review critically examines radiological assessment, biological context, prognostic implications, artificial intelligence (AI)-enabled quantification, and interventional evidence in PDAC. A structured narrative search of PubMed/MEDLINE, Embase, and Google Scholar was conducted from database inception through July 31, 2026. Computed tomography (CT)-based skeletal muscle index remains the most widely validated imaging biomarker, although substantial heterogeneity persists in methods and diagnostic thresholds. Low muscle mass is most consistently associated with reduced survival, whereas associations with postoperative morbidity and systemic treatment toxicity are more heterogeneous. Exercise, nutritional, and multimodal cachexia interventions appear feasible and may provide functional or nutritional benefits, but evidence remains insufficient to establish a survival benefit from improving muscle status. AI-based approaches enable scalable body-composition analysis, although external validation, methodological standardization, and prospective clinical integration remain necessary. Overall, radiological sarcopenia is a promising prognostic and potentially actionable phenotype in PDAC.